Hi 

I agree I would rather know about any transcutaneous measurements that are going on. 

The POCT team are best placed to give advice on how they should test it before going into use. There is also overlap between these systems, other POCT and the lab. If a patient has tests on all 3 systems then clinicians should know the difference between each so they can manage their patients more effectively.

That makes it sound easy which it is not!!

Thanks



Ann Marie



Ann Marie Carroll

Pathology POCT Manager

Nottingham University Hospitals Trust

0115-9249924 x 61653

 

Help us prevent infections at our hospitals by cleaning your hands. Remember - hand washing is the simplest and most effective way of preventing infections.



-----Original Message-----

From: ACB Point-of-Care Testing [mailto:[log in to unmask]] On Behalf Of Ryder David (UHMB)

Sent: 20 June 2016 14:54

To: [log in to unmask]

Subject: transcutaneous Measurement POCT or Not.



Hi



I'm afraid the authors of ISO 22870 would disagree as the scope (paragraph 1) of this standard (and 15189) says that as a quality management system, it can be applied to transcutaneous methods. This is particularly pertinent in light of the introduction of the Masimo Hb sensor. I would rather know that these exist in my organisation and have an idea of what is happening with them, than them just appearing through Medical engineering.



Thanks, 



David Ryder, Point of Care Testing Coordinator



University Hospitals of Morecambe Bay NHS Foundation Trust Furness General Hospital Dalton Lane Barrow-in-Furness, Cumbria, LA14 4LF



External: 01229 491171 | Extension: 51171 | Mobile: 07580 818900



-----Original Message-----

From: ACB Point-of-Care Testing [mailto:[log in to unmask]] On Behalf Of Brown Stephen (THE PATHOLOGY PARTNERSHIP)

Sent: 20 June 2016 10:12

To: [log in to unmask]

Subject: Re: ACB-POCT Digest - 7 Jun 2016 to 8 Jun 2016 (#2016-78)



This is an interesting study and would welcome sight of the results for future reference.



However when we have reviewed this sort of equipment, for POCT support, we decided as this did not involve a sample then this did not constitute a POCT test in the true sense of the word.



What are other users view on the status of this piece of equipment, POCT or not?



Stephen



Stephen Brown CSci FIBMS



POCT  Manager, The Pathology Partnership Iconix One | Iconix Park | London Road | Pampisford |CAMBRIDGE CB22 3EG



M:  07487 777259

L  :  01223 632933



E  :  [log in to unmask]



The Pathology Partnership is an NHS pathology provider | http://thepathologypartnership.info/











Date:    Wed, 8 Jun 2016 19:24:52 +0100

From:    Joanne Morris <[log in to unmask]>

Subject: Draeger transcutaneous bilirubinometer evaluation/audit



We are planning a clinical audit of the use of the Draeger transcutaneous bilirubinometers used by our community midwife team. The aim of the audit is to assess the clinical effectiveness of the meters in screening babies who require referral and treatment and to compare the values from the meter  to the results produced when they babies arrive at the hospital for further assessment.



I was wondering if anyone else has audited the use of this instrument and would be willing to share the structure and content of the audit? I would also be interested in any evaluation data comparing the meters to lab methods or other available POCT methods for bilirubin?



Best wishes

Joanne Morris

Consultant Clinical Scientist

Whittington Health



------------------------------



End of ACB-POCT Digest - 7 Jun 2016 to 8 Jun 2016 (#2016-78)

************************************************************





********************************************************************************************************************



This message may contain confidential information. If you are not the intended recipient please inform the sender that you have received the message in error before deleting it.

Please do not disclose, copy or distribute information in this e-mail or take any action in reliance on its contents:

to do so is strictly prohibited and may be unlawful.



Thank you for your co-operation.



NHSmail is the secure email and directory service available for all NHS staff in England and Scotland NHSmail is approved for exchanging patient data and other sensitive information with NHSmail and GSi recipients NHSmail provides an email address for your career in the NHS and can be accessed anywhere For more information and to find out how you can switch, visit www.connectingforhealth.nhs.uk/nhsmail



********************************************************************************************************************



The information contained in this email may be the subject of public disclosure under the

Freedom of Information Act 2000 - unless legally exempt from disclosure, the

confidentiality of this email and your reply cannot be guaranteed.



Copyright of this email and any attachments created by us remains vested in the

Nottingham University Hospitals NHS Trust.



This email and any files transmitted with it are confidential and intended solely for 

the use of the individual or entity to whom they are addressed. 



This footnote also confirms that this email message has been swept by 

anti-virus software for the presence of known computer viruses.





Nottingham University Hospitals NHS Trust

City Hospital campus | Hucknall Road | Nottingham | NG5 1PB | Tel: 0115 969 1169

QMC campus | Derby Road | Nottingham | NG7 2UH | Tel: 0115 924 9924



If you have received this email in error please notify the sender. 





--------------------------------------------------------------------------------



Tracking ID: B57694c0c0000.000000000001.0003.mml - 15:15:41  21/06/2016